Esperion Therapeutics, Inc. - Common Stock (NQ:ESPR)
2.470
-0.120
(-4.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 6,290,826 |
| Open | 2.560 |
| Bid (Size) | 2.470 (700) |
| Ask (Size) | 2.500 (2,500) |
| Prev. Close | 2.590 |
| Today's Range | 2.410 - 2.575 |
| 52wk Range | 0.6925 - 4.175 |
| Shares Outstanding | 28,277,493 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Esperion to Participate in The 2026 Citizens Life Sciences Conference
February 18, 2026
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 06, 2025
Frequently Asked Questions
Is Esperion Therapeutics, Inc. - Common Stock publicly traded?
Yes, Esperion Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Esperion Therapeutics, Inc. - Common Stock trade on?
Esperion Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Esperion Therapeutics, Inc. - Common Stock?
The ticker symbol for Esperion Therapeutics, Inc. - Common Stock is ESPR on the Nasdaq Stock Market
What is the current price of Esperion Therapeutics, Inc. - Common Stock?
The current price of Esperion Therapeutics, Inc. - Common Stock is 2.470
When was Esperion Therapeutics, Inc. - Common Stock last traded?
The last trade of Esperion Therapeutics, Inc. - Common Stock was at 03/12/26 04:00 PM ET
What is the market capitalization of Esperion Therapeutics, Inc. - Common Stock?
The market capitalization of Esperion Therapeutics, Inc. - Common Stock is 69.85M
How many shares of Esperion Therapeutics, Inc. - Common Stock are outstanding?
Esperion Therapeutics, Inc. - Common Stock has 70M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.